Skip to main content
. 2009 Dec 14;54(2):673–677. doi: 10.1128/AAC.01353-09

TABLE 1.

Percentage of MIC and MPC values at CLSI breakpoints for all strains testeda

Drug and parameter % of strains in each breakpoint category
Susceptible Intermediate Resistant
Levofloxacin
    MIC 66 3 31
    MPC 18 42 40
Moxifloxacin
    MIC 71 6 23
    MPC 57 9 34
Gemifloxacin
    MIC 67 4 29
    MPC 14 28 58
a

The CLSI breakpoints (6) are as follows for the three drugs: for levofloxaxin, ≤2 μg/ml for susceptible, 4 μg/ml for intermediate, and ≥8 μg/ml for resistant; for moxifloxacin, ≤1 μg/ml for susceptible, 2 μg/ml for intermediate, and ≥4 μg/ml for resistant; for gemifloxacin, ≤0.125 μg/ml for susceptible, 0.25 μg/ml for intermediate, and ≥0.5 μg/ml for resistant.